Barely Significant
← all excerpts

Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy.

Mol Ther Oncolytics · 2016 · PMC5040171 · PMID 27738655

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

highly significantP < 0.001actually significant
Hence, treatment with VSV-GP provided a highly significant survival benefit ( P < 0.001, log-rank test).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.